1st Circ. Panel Seems Poised to Uphold RI Drug Pricing Law
The majority of a First Circuit panel seemed unlikely Wednesday to upend a Rhode Island law that blocks drug manufacturers from imposing restrictions on healthcare providers and contract pharmacies in a federal prescription...To view the full article, register now.
Already a subscriber? Click here to view full article